Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger

Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger

Submitted by admin on August 26, 2019 - 10:24am
Source: 
Stat
News Tags: 
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
Headline: 
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
snippet: 

Amgen said Monday that it will buy the psoriasis pill Otezla from Celgene, which is selling the medicine to remove an antitrust obstacle from its planned merger with Bristol-Myers Squibb.

Do Not Allow Advertisers to Use My Personal information